CIK 0000946644
- Non-accelerated filer
- Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 520845822
- Phone
- +1 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- Open-market buys, last 90 days
- $52,276
- in 13 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$52,276. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 64 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-12 | CHEMEROW DAVID I. Director | Conversion | +25,000 | 28,441 | ||
| 2026-03-12 | CHEMEROW DAVID I. Director | Conversion · Series G Convertible Prefered Stock | −25 | 0 | ||
| 2026-03-06 | CHEMEROW DAVID I. Director | Other acquisition · Series G Convertible Preferred Stock | +25 | $25,000.00 | $625K | 25 |
| 2026-03-06 | CHEMEROW DAVID I. Director | Other acquisition · Class G Warrants | +50,000 | 50,000 | ||
| 2026-02-05 | CHEMEROW DAVID I. Director | Grant or award | +2,800 | $1.23 | $3K | 3,441 |
| 2025-03-14 | CHEMEROW DAVID I. Director | Grant or award | +44,899 | $0.12 | $5K | 64,189 |
| 2025-02-28 | CHEMEROW DAVID I. Director | Grant or award | +19,290 | $0.14 | $3K | 19,290 |
Page 1 of 1 · 7 trades